IP
IVELISSE PORROA-GARCIA
CROSSROADS STRATEGIES, LLC · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
39
last 3 years
Filings
110
19 agencies contacted
Activity
filings by quarter
Works on
Taxation/Internal Revenue Code 45Health Issues 37Trade (domestic/foreign) 25Medicare/Medicaid 18Budget/Appropriations 16Homeland Security 14Energy/Nuclear 12Financial Institutions/Investments/Securities 12Insurance 10Copyright/Patent/Trademark 9Computer Industry 7Banking 6Transportation 5Manufacturing 5Indian/Native American Affairs 3Communications/Broadcasting/Radio/TV 3Environment/Superfund 3Gaming/Gambling/Casino 3Government Issues 3Labor Issues/Antitrust/Workplace 3Law Enforcement/Crime/Criminal Justice 3Telecommunications 3Tobacco 3Medical/Disease Research/Clinical Labs 2Veterans 2Fuel/Gas/Oil 2Pharmacy 2Science/Technology 2Defense 1
Background
Government experience
Policy Director
Congressional Hispanic Caucus (CHC); Legislative Assistant, Rep. Raul Ruiz; Staff Assistant, Sen. Barbara Boxer
Disclosed on LD-2 filings
Career
CS
Specific issues
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies. S.3832/H.R.7142, Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.
Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues.
General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Drug Pricing; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; CMMI Proposed Accelerated Approval Payment Policy; CMMI Medicaid Proposed Rebate Rule.
Issues related to federal health programs and prescription drugs; H.R.9027/S.4690, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025; H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025.
Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, plasma therapy, and step therapy; H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169) implementation; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; H.R.830, HELP Copays Act; S.127, Pharmacy Benefit Manager Transparency Act of 2023; H.R.3285, Fairness for Patient Medications Act; S.1339, Pharmacy Benefit Manager Reform Act; H.R.5378, Lower Costs, More Transparency Act; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring PBM Accountability Act; H.R.6283, DRUG Act; H.R.2630, Safe Step Act.
Clients
Filing history
TAKEDA PHARMACEUTICALS AMERICA, INC.
VERTEX PHARMACEUTICALS INCORPORATED
COHERE US, INC.
INDIVIOR INC.
SOFTWARE & INFORMATION INDUSTRY ASSOCIATION (SIIA)
VISA, INC.
H&R BLOCK MANAGEMENT, LLC
UNITED STATES STEEL CORPORATION
AVENTIV TECHNOLOGIES LLC AND VARIOUS SUBSIDIARIES
ALABAMA-COUSHATTA TRIBE OF TEXAS
TIKTOK INC.
PARALLEL SYSTEMS